Use of cellular biotechnologies in treatment metastatic pericarditis at patients with tumors of female reproductive system

Malignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokine-activated killers and interleukin-2 immunotherapy...

Full description

Saved in:
Bibliographic Details
Main Authors: K. S. Titov (Author), S. M. Volkov (Author), L. V. Demidov (Author), A. N. Gritsay (Author), N. I. Lazareva (Author), M. V. Kiselevskiy (Author), A. P. Nikolayev (Author)
Format: Book
Published: ABV-press, 2014-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malignant pericardial effusions often arise in patients with breаst cancer and ovarian cancer. Sistem antitumor therapy is uneffective in gen- erally and causes side effects. Here we show that intrapericardial interleukin-2 with allogenеc lymphokine-activated killers and interleukin-2 immunotherapy demonstrated the high efficacy in threatment of breаst and ovarian cancer patients with malignant pericardial effusions. The objective effect was 92.3 % аnd 90.0 % accordingly. These results indicates that intrapericardial immunotherapy might be one of the stages of combined treatment of such group of patients. The suggested type of biotherapy increases the survival and life quality of patients.
Item Description:1994-4098
1999-8627
10.17650/1994-4098-2013-0-3-4-101-104